Related Experiment Video
Updated: May 7, 2026
Encapsulated Cell Technology for the Delivery of Biologics to the Mouse Eye
Published on: March 30, 2020
Cell-based therapies for ocular disease
1E&B Technologies, LLC, San Diego, California.
Abstract:
Cell therapy for ocular disease has made significant progress within the last decade. Stem and progenitor populations for many ocular cell types have been identified, and their behavior is now understood well enough to enable clinical application. Corneal epithelial progenitor cell therapy has benefited many patients and is now transitioning from a research technique to established clinical therapy. The application of embryonic stem cell-based therapy is in clinical development for Stargardt's macular dystrophy and dry age-related macular degeneration. These advances have been made possible, in part, by the inherent advantages of the eye as a place to develop and apply cell therapies and the foundation built on transplantation studies. Despite these advances, there are still areas of high unmet need that could benefit from cell therapy when further research identifies methods to identify, generate, and manipulate the progenitor populations. This review discusses, in practical terms, the application of cell therapies to the eye, progress that has been made and progress which remains to be made in the application of cell therapy to ocular disease.
Insights
Cell therapy shows promise for eye diseases, with corneal treatments established and stem cell therapies advancing for conditions like macular degeneration. Further research is needed to address remaining unmet needs in ocular cell therapy.
Area of Science:
- Ophthalmology
- Regenerative Medicine
- Cell Biology
Background:
- Cell therapy has advanced significantly for ocular diseases over the past decade.
- Identification and understanding of stem and progenitor cells are key to clinical applications.
- The eye's unique properties facilitate cell therapy development and transplantation studies.
Purpose of the Study:
- To review the current applications of cell therapy in treating ocular diseases.
- To discuss progress made in the field of ocular cell therapy.
- To identify areas of unmet need and future research directions for cell therapy in ophthalmology.
Main Methods:
- Review of current literature on cell therapy for ocular diseases.
- Analysis of clinical trial progress for stem cell-based therapies.
- Discussion of challenges and opportunities in progenitor cell identification and manipulation.
Main Results:
- Corneal epithelial progenitor cell therapy is transitioning to established clinical practice.
- Embryonic stem cell-based therapies are in clinical development for Stargardt's macular dystrophy and dry age-related macular degeneration.
- Advances are partly due to the eye's suitability for cell therapy and prior transplantation research.
Conclusions:
- Cell therapy offers significant potential for treating a range of ocular diseases.
- Established corneal cell therapies and developing stem cell treatments highlight current progress.
- Further research is crucial to identify, generate, and manipulate progenitor populations for unmet needs in ocular disease treatment.
More Related Videos
06:16Subconjunctival Administration of Adeno-associated Virus Vectors in Small Animal Models
Published on: March 16, 2022
11:13Adenoviral Gene Therapy for Diabetic Keratopathy: Effects on Wound Healing and Stem Cell Marker Expression in Human Organ-cultured Corneas and Limbal Epithelial Cells
Published on: April 7, 2016
Related Concept Videos
01:22iPS Cell Differentiation
01:23Ophthalmic Drug Delivery Systems